1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. DIVI'S LABORATORIES LTD.
Divi's Laboratories Ltd.
NSE: DIVISLAB | BSE: 532488
Expensive Star
Download real time
US FDA Inspections
Ask AI about Divi's Laboratories
9285.00-141.00(-1.50%)
Near 52W High of ₹9740.00
429.3K
NSE+BSE Volume

NSE 13 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Divi's Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Divi's Laboratories share price target, revenues, EPS, net income and more

Divi's Laboratories quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • POSITIVE

    Quarterly Revenue Divi's Laboratories Jun-2026 Quarterly Revenue is Rs 3,037 Cr which is growth of 22.7% YoY.

  • POSITIVE

    Quarterly Net Profit Divi's Laboratories Jun-2026 Quarterly Net Profit is Rs 891 Cr which is growth of 60.0% YoY.

Divi's Laboratories Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
⌄
3,0372,9472,6652,8062,4762,6232,3792,4072,1422,3381,9021,9531,810
Operating Exp.
1,7341,8501,6711,7651,6141,6551,5501,5731,4421,5421,3171,3941,239
Operating Profit
1,240943907895743881747729621717491474491
Operating Profit Margin %
41.69%33.76%35.18%33.65%31.52%34.74%32.52%31.67%30.10%31.74%27.16%25.37%28.38%
Depr.
13212011611311210799989794959493
Interest
66683121
Profit Before Tax
1,165971798920747861730735603700490464478
Tax
274215200224190194136217173169132122133
Net Profit
891756598696557667594518430531358342345
EPS Adj. latest
33.628.522.526.22125.122.419.516.22013.512.913
Net profit TTM
2,9412,6072,5182,5142,3362,2092,0731,8371,6611,5761,363.81,316.71,461.5
Basic EPS TTM
11198.49594.988.283.478.269.362.759.551.549.755.2
Earnings Transcripts
AI Summary
   
  
Results PDF
      
Result Notes
Notes
Notes
Notes
Notes
Notes
 
Notes
Notes
Notes
Notes
Notes
Notes
Notes
*All financials are in INR Cr and price data in INR
Add metric to table
Search...

Divi's Laboratories competitor comparison and performance snapshot within industry

Divi's Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue Divi's Laboratories Mar-2026 Annual Revenue is Rs 10,894 Cr which is growth of 14.1% YoY.

  • POSITIVE

    Annual Net Profit Divi's Laboratories Mar-2026 Annual Net Profit is Rs 2,607 Cr which is growth of 18.0% YoY.

Divi's Laboratories Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
⌄
11%
9.7%
11,45510,8949,5508,0027,974.38,991.16,861.15,500.45,036.23,928.44,099.83,815.7
Operating Exp. Ann.
9.3%
11.6%
7,0206,9006,2195,4915,277.65,003.43,977.93,495.13,030.72,565.32,586.12,323.5
Operating Profit Ann.
14.1%
4.3%
3,9853,4882,9792,1742,347.73,876.52,820.71,815.41,8491,250.61,437.81,397.9
OPM Ann. %
2.8%
-4.9%
 32.02%31.19%27.17%29.44%43.11%41.11%33.01%36.71%31.84%35.07%36.63%
⌄
9.5%
11.8%
 7,3846,6215,8705,620.25,314.64,233.33,687.13,2032,709.12,711.62,443.9
EBITDA Ann.
14%
6.7%
 3,9943,3312,5112,696.73,987.72,883.22,005.32,005.51,363.11,513.71,492.3
EBITDA Ann. margin %
2.7%
-2.7%
 36.66%34.88%31.38%33.82%44.35%42.02%36.46%39.82%34.70%36.92%39.11%
Interest Ann.
258.3%
101.1%
2623130.50.70.76.13.51.32.32.3
Depr.
10.5%
12.6%
481461401376342.1310.6254.7186168.8142.4123.3118.1
PBT Ann.
13.4%
5.5%
3,8543,4362,9292,1322,354.13,676.52,627.91,813.31,833.21,219.41,388.21,371.8
Tax Ann.
14.9%
4.3%
913829720556546728673.2440.6500.6349.8335264.1
⌄
13%
5.9%
 2,6072,2091,5761,808.22,948.51,954.71,372.71,332.7869.61,053.31,107.7
Net Profit Ann.
13%
5.9%
2,9412,6072,2091,5761,808.22,948.51,954.71,372.71,332.7869.61,053.31,107.7
NPM Ann. %
1.9%
-2.7%
 25.09%24.01%20.56%23.71%33.20%28.75%25.84%27.31%22.78%26.17%29.76%
EPS Adj. latest Ann.
13%
5.9%
 98.283.259.468.1111.173.651.750.232.839.741.7
Result Notes
 
Notes
 
Notes
Notes
Notes
Notes
Notes
Notes
Notes
Notes
 
Annual Reports
 
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
14.1%
2Y CAGR
16.7%
3Y CAGR
11%
5Y CAGR
9.7%
7Y CAGR
11.7%
10Y CAGR
11.1%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
1Y CHG
18%
2Y CAGR
28.6%
3Y CAGR
13%
5Y CAGR
5.9%
7Y CAGR
10.1%
10Y CAGR
8.9%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
11%
2Y CAGR
12.1%
3Y CAGR
9.3%
5Y CAGR
11.6%
7Y CAGR
12.5%
10Y CAGR
11.5%
Operating Expenses Annual Cr growth is stable compared to historical averages.

Divi's Laboratories balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Divi's Laboratories Mar-2026 Total Shareholders Fund is Rs 16,711 Cr which is growth of 12.2% YoY.

  • POSITIVE

    Total Assets Divi's Laboratories Mar-2026 Total Assets is Rs 19,954 Cr which is growth of 18.6% YoY.

Divi's Laboratories Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
⌄
9.6%
12.5%
16,71114,89513,48412,705.411,691.49,271.67,316.76,973.35,959.75,408.94,350.1
Minority Interest Liability Ann.
-
-
-----------
⌄
29.2%
27.5%
1,224509619567.8448.1363.3294.5234.4207.6145.3161.2
⌄
23.2%
13.1%
2,0191,4201,2591,078.41,168.41,088.9902.9832.5640.5655.8516.1
Total Capital Plus Liabilities Ann.
11.6%
13.2%
19,95416,82415,36214,351.613,307.910,723.88,514.18,040.26,807.86,210.15,027.5
⌄
20.5%
14.4%
8,6336,4625,5154,930.64,790.94,409.63,6962,579.42,115.62,002.51,702.6
⌄
20.4%
14.2%
8,9206,8455,7905,116.25,011.94,598.53,852.93,392.72,253.92,170.91,908.4
⌄
6.1%
12.5%
11,0349,9799,5729,235.58,2966,125.34,661.24,647.54,553.94,039.23,119.1
Total Assets Ann.
11.6%
13.2%
19,95416,82415,36214,351.613,307.910,723.88,514.18,040.26,807.86,210.15,027.5
Contingent Liabilities plus Commitments Ann.
46.9%
16.1%
2,3361,8411,4327371,259.91,107.11,223.81,031.4278.9388.8273.8
Bonus Equity Share Capital Ann.
0%
0%
39.739.739.739.739.739.739.739.739.739.739.7
Non Current Investments Unquoted Book Value Ann.
-3.4%
59.3%
76728984.479.47.47.47.47.48.42.8
Current Investments Unquoted Book Value Ann.
-
-
802.5
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
18.6%
2Y CAGR
14%
3Y CAGR
11.6%
5Y CAGR
13.2%
7Y CAGR
13.9%
10Y CAGR
14.8%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
42.2%
2Y CAGR
26.6%
3Y CAGR
23.2%
5Y CAGR
13.1%
7Y CAGR
13.5%
10Y CAGR
14.6%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
12.2%
2Y CAGR
11.3%
3Y CAGR
9.6%
5Y CAGR
12.5%
7Y CAGR
13.3%
10Y CAGR
14.4%
Total ShareHolders Funds Annual growth is stable compared to historical averages.

Divi's Laboratories ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Book Value Per Share Divi's Laboratories Mar-2026 Book Value Per Share is 631 Rs which is growth of 12.2% YoY.

  • POSITIVE

    ROE Divi's Laboratories Mar-2026 ROE is 16% which is growth of 0.8% YoY.

Divi's Laboratories Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
BVSH Ann.
9.6%
12.5%
630.6562.1508.8478.6440.4349.3275.6262.7224.5203.8163.9
RoA Ann. %
1.2%
-6.4%
13.06%13.13%10.25%12.59%22.15%18.22%16.12%16.57%12.77%16.96%22.03%
ROE Ann. %
3.1%
-5.8%
15.60%14.83%11.68%14.23%25.21%21.08%18.76%19.11%14.59%19.47%25.46%
ROCE Ann. %
3.6%
-6.3%
19.69%19.02%15.13%17.73%30.29%27.28%23.90%25.48%19.79%25.03%30.45%
⌄
           
⌄
           
⌄
           
Total Debt to Total Equity Ann.
       0000
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
5.2%
2Y CAGR
15.6%
3Y CAGR
3.1%
5Y CAGR
-5.8%
7Y CAGR
-2.9%
10Y CAGR
-4.8%
ROE Annual % is growing faster than historical averages.
RoA Ann. %
1Y CHG
-0.5%
2Y CAGR
12.9%
3Y CAGR
1.2%
5Y CAGR
-6.4%
7Y CAGR
-3.3%
10Y CAGR
-5.1%
RoA Annual % is falling faster than historical averages.
Current Ratio Ann.
1Y CHG
-21.4%
2Y CAGR
-14.9%
3Y CAGR
-13.8%
5Y CAGR
-0.4%
7Y CAGR
-0.3%
10Y CAGR
-0.9%
Current Ratio Annual is falling faster than historical averages.

Divi's Laboratories cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity Divi's Laboratories Mar-2026 Cash From Operating Activity is Rs 2,711 Cr which is growth of 64.3% YoY.

  • NEGATIVE

    Net Cash Flow Divi's Laboratories Mar-2026 Net Cash Flow is Rs -309 Cr which is growth of -718.0% YoY.

Divi's Laboratories Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
⌄
3.5%
6.8%
2,7111,6501,2662,4481,910.21,947.11,208.5964.1764.71,149.11,032.4
Cash from Investing Act. Ann.
-
-
-2,218-803-268-2,706.8-2,195.475.3-81.4-684.2-475.9-1,137.4-413.4
Cash from Financing Act. Ann.
-
-
-802-797-798-796.6-531.5-34-1,091.3-245.9-314.23.3-624.1
⌄
-
-
-30950200-1,055.4-816.71,988.435.833.9-25.315-5.2
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
64.3%
2Y CAGR
46.3%
3Y CAGR
3.5%
5Y CAGR
6.8%
7Y CAGR
15.9%
10Y CAGR
10.1%
Cash from Operating Activity Annual growth is higher than historical averages.

Divi's Laboratories investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Ask AI
×